Zivo Bioscience, Inc. (ZIVO) stock
ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$6.80+0.30 (+4.62%)
Close on Oct 19, 2026Market cap $25.96MP/E –Yield –
Zivo Bioscience ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Zivo Bioscience's ebitda for the twelve months ending Jun 30, 2021 was -$8.95M. For fiscal 2021 it was -$8.65M. The highest annual figure on record is -$1.85M in fiscal 2011.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | -$8.65M | – |
| FY2020 | Dec 31, 2020 | -$8.56M | – |
| FY2019 | Dec 31, 2019 | -$8.35M | – |
| FY2018 | Dec 31, 2018 | -$6.13M | – |
| FY2017 | Dec 31, 2017 | -$6.31M | – |
| FY2016 | Dec 31, 2016 | -$3.47M | – |
| FY2015 | Dec 31, 2015 | -$3.03M | – |
| FY2014 | Dec 31, 2014 | -$5.13M | – |
| FY2013 | Dec 31, 2013 | -$3.09M | – |
| FY2012 | Dec 31, 2012 | -$2.01M | – |
| FY2011 | Dec 31, 2011 | -$1.85M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2021 | Jun 30, 2021 | -$1.75M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.08M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.76M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.36M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.03M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.41M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.77M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.57M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.04M | – |
| Q1 FY2019 | Mar 31, 2019 | -$967.85K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.62M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.49M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.34M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.68M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.60M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.05M | – |
| Q2 FY2017 | Jun 30, 2017 | -$875.20K | – |
| Q1 FY2017 | Mar 31, 2017 | -$785.02K | – |
| Q4 FY2016 | Dec 31, 2016 | -$636.41K | – |
| Q3 FY2016 | Sep 30, 2016 | -$670.87K | – |
| Q2 FY2016 | Jun 30, 2016 | -$1.52M | – |
| Q1 FY2016 | Mar 31, 2016 | -$634.31K | – |
| Q4 FY2015 | Dec 31, 2015 | -$657.50K | – |
See a number that looks wrong?